T78.41
Arthus phenomenon
Clinical Classification Guidelines
Inclusion Terms
- Arthus reaction
Medical Intelligence & Overview
The Arthus phenomenon, also known as the Arthus reaction, is a localized inflammatory response that occurs after the injection of certain vaccines or medicines. It is characterized by swelling, pain, and redness at the injection site and results from an immune system reaction that causes inflammation. Although it is relatively rare, understanding this immune response is important for recognizing its signs and managing it appropriately.
Causes & Symptoms
Clinical Causes: Recent vaccination or injection of serum or antiserum Repeated exposure to specific vaccines or therapeutic agents containing antigens High levels of circulating antibodies that react with injected antigens Inappropriate timing between subsequent doses of vaccines or serum injections
Key Symptoms: Localized swelling and lumps at the injection site Redness and warmth in the affected area Pain or tenderness during touch In some cases, skin ulceration or necrosis Rarely, systemic signs such as fever or malaise
Diagnostic & Treatment
Diagnosis Path: Diagnosis of the Arthus phenomenon primarily involves clinical evaluation. A healthcare provider reviews the patient's recent medical history, particularly any recent vaccinations or injections. The characteristic appearance of the lesion and timing—usually within hours of exposure—support the diagnosis. Additional tests like skin biopsy may be performed in atypical or persistent cases, showing immune complex deposits and inflammation. Laboratory studies revealing elevated antibody levels may also support the diagnosis.
Treatment Protocols: Management of the Arthus reaction focuses on alleviating symptoms and preventing secondary infections. Common approaches include: - Applying cold compresses to reduce swelling and pain - Use of over-the-counter pain relievers such as acetaminophen or nonsteroidal anti-inflammatory drugs (NSAIDs) - Elevating the affected limb to decrease swelling - Monitoring for signs of infection or ulceration - In severe cases, healthcare providers may prescribe corticosteroids to reduce inflammation Prevention involves careful timing of repeat doses of vaccines or serums, especially in individuals with known prior reactions. Patients should inform healthcare providers about any previous similar responses.
Clinical Advice & FAQs
Billing Guidance
Is T78.41 a billable ICD-10 code?
Yes, T78.41 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T78.41?
Clinical documentation must specify the nature of Arthus phenomenon and any associated comorbidities for accurate reporting.
Cite this Clinical Reference